Standout Papers

Surveillance for Adverse Events After COVID-19 mRNA Vaccination 2021 2026 2022 2024411
  1. Surveillance for Adverse Events After COVID-19 mRNA Vaccination (2021)
    Nicola P. Klein, Ned Lewis et al. JAMA
  2. Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system (2023)
    Joseph A. Lewnard, John M. McLaughlin et al. The Lancet Infectious Diseases

Immediate Impact

4 by Nobel laureates 2 from Science/Nature 58 standout
Sub-graph 1 of 20

Citing Papers

Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK
2024 Standout
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice
2024 Standout
2 intermediate papers

Works of Bruno Lewin being referenced

Surveillance for Adverse Events After COVID-19 mRNA Vaccination
2021 Standout
Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older
2021

Author Peers

Author Last Decade Papers Cites
Bruno Lewin 626 224 216 58 1.1k
Kristin Goddard 541 309 335 48 1.2k
Kayla E. Hanson 655 295 277 32 1.4k
Anne M. Hause 739 350 262 34 1.1k
Doron Netzer 899 255 238 33 1.4k
Jonathan Duffy 572 262 526 58 1.4k
Danielle Moulia 751 406 320 31 1.3k
M. Cecilia Gonzalez Corcia 553 280 97 54 973
Paige Lewis 321 399 654 46 1.1k
John Iskander 321 261 367 24 917
Yuansheng Hu 1011 306 183 27 1.3k

All Works

Loading papers...

Rankless by CCL
2026